Originally identified as a gene upregulated during apoptosis [44], PDCD4 functions as a translational repressor by binding to eukaryotic translation initiation factors, thereby inhibiting protein synthesis required for tumor progression [45,46]. The gene discussed is PDCD4; the disease is neoplasm.